SCHEMBL29698232

SCHEMBL29698232

COc1cc(Br)ncc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.36
PDGFRA P16234 4/20 0.36
ALDH1A1 P00352 3/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
HTT P42858 1/20 0.34
P2RX3 P56373 1/20 0.34
P2RX2 Q9UBL9 1/20 0.34
EGFR P00533 2/20 0.33
KDR P35968 2/20 0.33
RET P07949 1/20 0.33
KIF5B P33176 1/20 0.33
AXL P30530 1/20 0.33
KDM1A O60341 1/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
KIT P10721 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21807891 1.00 PDGFRB (0.36) PDGFRBPDGFRAALDH1A1PIK3CAMTOR
SCHEMBL27038119 0.83 PDGFRB (0.38) PDGFRBPDGFRAALDH1A1PIK3CAMTOR
SCHEMBL8118182 0.81 DRD1 (0.39) PDGFRBPDGFRAALDH1A1HTTP2RX3
SCHEMBL23976562 0.80 ALDH1A1 (0.44) PDGFRBPDGFRAALDH1A1AXLGAA
SCHEMBL1827513 0.80 ALDH1A1 (0.39) PDGFRBPDGFRAALDH1A1HTTP2RX3
SCHEMBL22978591 0.80 SMN1; SMN2 (0.38) ALDH1A1HTTKDM1AGAAL3MBTL1
SCHEMBL15933053 0.78 AXL (0.43) ALDH1A1P2RX3P2RX2AXLPOLB
SCHEMBL18348256 0.77 NQO2 (0.37) PDGFRBPDGFRAALDH1A1P2RX3P2RX2
SCHEMBL2610403 0.77 SLC6A4 (0.41) PDGFRBPDGFRAALDH1A1HTTP2RX3
SCHEMBL24509373 0.76 GRIN1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010334-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS Novartis AG (CH) 2022-06-15 EP disclosed